5 ESSENTIAL ELEMENTS FOR MBL77

Not all individuals with CLL require therapy. Regardless of all recent advancements, the iwCLL even now endorses watchful observation for patients with asymptomatic disorder.86 This advice relies on no less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,1